Results 211 to 220 of about 2,748,163 (380)

Unsupervised non‐small cell lung cancer tumor segmentation using cycled generative adversarial network with similarity‐based discriminator

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Background Tumor segmentation is crucial for lung disease diagnosis and treatment. Most existing deep learning‐based automatic segmentation methods rely on manually annotated data for network training. Purpose This study aims to develop an unsupervised tumor segmentation network smic‐GAN by using a similarity‐driven generative adversarial ...
Chengyijue Fang, Xiaoyang Li, Yidong Yang   +2 more
wiley   +1 more source

Cost-Effectiveness Analysis of Hepatitis E Vaccination Strategies for Swine Workers. [PDF]

Transbound Emerg Dis
Wang F, Zhou L, Lu Y.
europepmc   +1 more source

II. Cost-Effectiveness Analysis of Psychiatric Deinstitutionalization [PDF]

, 2000
Daniel Reinharz, Alain Lesage, André‐Pierre Contandriopoulos   +2 more
openalex   +1 more source

Microarray patch vaccines for typhoid conjugate vaccines: A global cost-effectiveness analysis. [PDF]

Vaccine
Antillon M, Verjans A, El Sheikh F, Scarna T, Mvundura M.   +4 more
europepmc   +1 more source

Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Myasthenia gravis (MG) clinical trials typically allow rescue therapy during follow‐up in the event of marked worsening of MG symptoms. Failure to appropriately address rescue therapy in defining treatment effects and planning statistical analyses may yield biased estimates, increase false positive rates, or decrease statistical power – all of
Justin M. Leach, Inmaculada Aban, Gary Cutter, Michael Benatar   +3 more
wiley   +1 more source

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial

Journal of the American Medical Association (JAMA), 2017
Dhruv S. Kazi, J. Penko, P. Coxson, Andrew E. Moran, D. Ollendorf, J. Tice, K. Bibbins‐Domingo   +6 more
semanticscholar   +1 more source

A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy. [PDF]

Hum Vaccin Immunother
Cherif A, Palmer C, Senese F, Bechini A, Salvati C, Bonanni P, Boccalini S.   +6 more
europepmc   +1 more source

Cost-effectiveness analysis for management of patients with ischemic heart disease

, 1995
Abdulmassih S. Iskandrian
openalex   +1 more source

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain–Barré syndrome

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Objectives Intravenous immunoglobulin (IVIg) is an effective treatment for Guillain–Barré syndrome (GBS), but recovery varies between patients. This study aims to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of a single and a second IVIg dose (SID) in patients with GBS.
Sander J. van Tilburg, Ruth Huizinga, Krista Kuitwaard, Sebastiaan D.T. Sassen, Christa Walgaard, Pieter A. van Doorn, Bart C. Jacobs, Birgit C.P Koch   +7 more
wiley   +1 more source

Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in Adults. [PDF]

Pharmacoecon Open
Briggs AH, Chalet FX, Cooper J, Graham P, Palmer S, Miller P, Walker A, Greenwood B, Morin CM.   +8 more
europepmc   +1 more source